Madrigal Pharmaceuticals Inc (MDGL)
$430.36 -0.31% Close Oct 30, 2026 Live
Madrigal Pharmaceuticals stock today
Madrigal Pharmaceuticals closed at $430.36 on October 30, 2026, down 0.31% on the day. Over the past year it returned +0.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $9.92 billion.
$500.00$600.00
NovJan 2026MarMayJulSep
| Period | MDGL | S&P 500 (SPY) |
|---|---|---|
| 1 month | -14.6% | -0.9% |
| 3 months | -12.7% | +2.1% |
| Year to date | -26.1% | +11.7% |
| 1 year | +0.7% | +12.4% |
| 3 years | +241.1% | +88.5% |
| 5 years | +453.5% | +76.0% |
Key statistics
- Market value
- $9.92B
- Price / sales
- 7.7
- 52-week range
- $412.35 to $602.83
- Next report
- Nov 3, 2026
About Madrigal Pharmaceuticals
Develops pharmaceutical products for liver disease, metabolic disorders, and related conditions.
Sector: Health Care
More on Madrigal Pharmaceuticals
- Returns: what $1,000 became$1,000 ten years ago is $25,556 today
No forecast, no recommendation. This page describes Madrigal Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.